Brevan Howard Capital Management’s ASML ASML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,408
Closed -$3.83M 2077
2026
Q1
$3.18M Buy
+2,408
New +$3.3M 0.03% 390
2024
Q2
Sell
-830
Closed -$805K 1060
2024
Q1
$805K Buy
+830
New +$736K 0.01% 320
2023
Q3
Sell
-3,200
Closed -$2.32M 391
2023
Q2
$2.32M Sell
3,200
-1,300
-29% -$884K 0.05% 52
2023
Q1
$3.06M Sell
4,500
-1,000
-18% -$642K 0.08% 62
2022
Q4
$3.01M Buy
5,500
+1,500
+38% +$786K 0.1% 43
2022
Q3
$1.66M Buy
+4,000
New +$2M 0.06% 43

Other funds holding ASML

Brevan Howard Capital Management's ASML Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of ASML (ASML) in Q2 2026, closing a stake of 2,408 shares — an estimated $3.83M sold.

Brevan Howard Capital Management first reported a position in ASML in Q3 2022 and held it in 6 quarters. The position peaked at $3.18M in Q1 2026. 2,498 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining ASML position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 2,408 ASML shares in Q2 2026, an estimated $3.83M.
  • Brevan Howard Capital Management first reported a position in ASML in Q3 2022 and held it in 6 quarters.
  • Brevan Howard Capital Management's ASML position peaked at $3.18M in Q1 2026.
  • 2,498 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.